The clinical performance of monoshade resin composite as posterior restoration: a randomized controlled clinical trial

Abstract The aim of this study was to assess the clinical performance of a monoshade universal resin composite as posterior restoration. Twenty adult patients having at least two carious lesions related to posterior teeth were selected. Each patient was provided with a monoshade resin composite (Omn...

Full description

Saved in:
Bibliographic Details
Main Authors: Ruba Salah Anwar, Yasser Fathi Hussein, Mona Riad
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-08857-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849763719490306048
author Ruba Salah Anwar
Yasser Fathi Hussein
Mona Riad
author_facet Ruba Salah Anwar
Yasser Fathi Hussein
Mona Riad
author_sort Ruba Salah Anwar
collection DOAJ
description Abstract The aim of this study was to assess the clinical performance of a monoshade universal resin composite as posterior restoration. Twenty adult patients having at least two carious lesions related to posterior teeth were selected. Each patient was provided with a monoshade resin composite (Omnichroma) and polyshade nanohybrid resin composite (Tetric® N-Ceram) for class I or II restorations. The performance of these restorations was assessed at 1, 3, 6, 9, and 12 months according to the modified United States Public Health Service (USPHS) criteria. Statistical analysis was carried out employing the Friedmann test and the Wilcoxon signed-rank test, with a significance level of p = 0.05. None of the restorations exhibited any clinical conditions warranting replacement. The monoshade universal group revealed prevalence of (Bravo) scores concerning the anatomic form, surface texture and post-operative sensitivity through the follow-up period (P = 0.317). For color match and color stability, the polyshade group revealed a statistically significantly higher incidence of (Alpha) scores after 9 and 12 months (P = 0.025). After 12-months of follow-up, the monoshade universal resin composite demonstrated satisfactory clinical performance. It can serve as a viable substitute for polyshade nanohybrid composite where chair side time is an essential concern.
format Article
id doaj-art-8ea7d06f434c47fe9ed4eaadee47c75c
institution DOAJ
issn 2045-2322
language English
publishDate 2025-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-8ea7d06f434c47fe9ed4eaadee47c75c2025-08-20T03:05:18ZengNature PortfolioScientific Reports2045-23222025-07-0115111410.1038/s41598-025-08857-8The clinical performance of monoshade resin composite as posterior restoration: a randomized controlled clinical trialRuba Salah Anwar0Yasser Fathi Hussein1Mona Riad2Conservative Dentistry Department, Faculty of Dentistry, Minia UniversityDental Materials Department, Faculty of Dentistry, Minia UniversityConservative Dentistry Department, Faculty of Dentistry, Cairo UniversityAbstract The aim of this study was to assess the clinical performance of a monoshade universal resin composite as posterior restoration. Twenty adult patients having at least two carious lesions related to posterior teeth were selected. Each patient was provided with a monoshade resin composite (Omnichroma) and polyshade nanohybrid resin composite (Tetric® N-Ceram) for class I or II restorations. The performance of these restorations was assessed at 1, 3, 6, 9, and 12 months according to the modified United States Public Health Service (USPHS) criteria. Statistical analysis was carried out employing the Friedmann test and the Wilcoxon signed-rank test, with a significance level of p = 0.05. None of the restorations exhibited any clinical conditions warranting replacement. The monoshade universal group revealed prevalence of (Bravo) scores concerning the anatomic form, surface texture and post-operative sensitivity through the follow-up period (P = 0.317). For color match and color stability, the polyshade group revealed a statistically significantly higher incidence of (Alpha) scores after 9 and 12 months (P = 0.025). After 12-months of follow-up, the monoshade universal resin composite demonstrated satisfactory clinical performance. It can serve as a viable substitute for polyshade nanohybrid composite where chair side time is an essential concern.https://doi.org/10.1038/s41598-025-08857-8Resin composite with a chameleon effectPolyshade nanohybrid resin compositeModified USPHSColor match and stability
spellingShingle Ruba Salah Anwar
Yasser Fathi Hussein
Mona Riad
The clinical performance of monoshade resin composite as posterior restoration: a randomized controlled clinical trial
Scientific Reports
Resin composite with a chameleon effect
Polyshade nanohybrid resin composite
Modified USPHS
Color match and stability
title The clinical performance of monoshade resin composite as posterior restoration: a randomized controlled clinical trial
title_full The clinical performance of monoshade resin composite as posterior restoration: a randomized controlled clinical trial
title_fullStr The clinical performance of monoshade resin composite as posterior restoration: a randomized controlled clinical trial
title_full_unstemmed The clinical performance of monoshade resin composite as posterior restoration: a randomized controlled clinical trial
title_short The clinical performance of monoshade resin composite as posterior restoration: a randomized controlled clinical trial
title_sort clinical performance of monoshade resin composite as posterior restoration a randomized controlled clinical trial
topic Resin composite with a chameleon effect
Polyshade nanohybrid resin composite
Modified USPHS
Color match and stability
url https://doi.org/10.1038/s41598-025-08857-8
work_keys_str_mv AT rubasalahanwar theclinicalperformanceofmonoshaderesincompositeasposteriorrestorationarandomizedcontrolledclinicaltrial
AT yasserfathihussein theclinicalperformanceofmonoshaderesincompositeasposteriorrestorationarandomizedcontrolledclinicaltrial
AT monariad theclinicalperformanceofmonoshaderesincompositeasposteriorrestorationarandomizedcontrolledclinicaltrial
AT rubasalahanwar clinicalperformanceofmonoshaderesincompositeasposteriorrestorationarandomizedcontrolledclinicaltrial
AT yasserfathihussein clinicalperformanceofmonoshaderesincompositeasposteriorrestorationarandomizedcontrolledclinicaltrial
AT monariad clinicalperformanceofmonoshaderesincompositeasposteriorrestorationarandomizedcontrolledclinicaltrial